131 related articles for article (PubMed ID: 16027527)
21. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions.
Khoeeniha MK; Esfandyari-Manesh M; Behrouz H; Amini M; Varnamkhasti BS; Atyabi F; Dinarvand R
Curr Drug Deliv; 2017; 14(8):1120-1129. PubMed ID: 27875950
[TBL] [Abstract][Full Text] [Related]
22. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.
Dharap SS; Qiu B; Williams GC; Sinko P; Stein S; Minko T
J Control Release; 2003 Aug; 91(1-2):61-73. PubMed ID: 12932638
[TBL] [Abstract][Full Text] [Related]
23. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound-responsive nanobubbles contained with peptide-camptothecin conjugates for targeted drug delivery.
Xie X; Lin W; Liu H; Deng J; Chen Y; Liu H; Fu X; Yang Y
Drug Deliv; 2016 Oct; 23(8):2756-2764. PubMed ID: 26289216
[TBL] [Abstract][Full Text] [Related]
25. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
[TBL] [Abstract][Full Text] [Related]
26. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
[TBL] [Abstract][Full Text] [Related]
27. Folate receptor-targeted theranostic IrS
Zhang DY; Zheng Y; Zhang H; Yang GG; Tan CP; He L; Ji LN; Mao ZW
Nanoscale; 2018 Dec; 10(47):22252-22262. PubMed ID: 30465053
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate.
Henne WA; Kularatne SA; Hakenjos J; Carron JD; Henne KL
Bioorg Med Chem Lett; 2013 Nov; 23(21):5810-3. PubMed ID: 24064501
[TBL] [Abstract][Full Text] [Related]
29. Preparation of Two Types of Polymeric Micelles Based on Poly(β-L-Malic Acid) for Antitumor Drug Delivery.
Yang T; Li W; Duan X; Zhu L; Fan L; Qiao Y; Wu H
PLoS One; 2016; 11(9):e0162607. PubMed ID: 27649562
[TBL] [Abstract][Full Text] [Related]
30. Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
Galbiati A; Tabolacci C; Morozzo Della Rocca B; Mattioli P; Beninati S; Paradossi G; Desideri A
Bioconjug Chem; 2011 Jun; 22(6):1066-72. PubMed ID: 21545180
[TBL] [Abstract][Full Text] [Related]
31. A new targeted delivery approach by functionalizing drug nanocrystals through polydopamine coating.
Zhan H; Jagtiani T; Liang JF
Eur J Pharm Biopharm; 2017 May; 114():221-229. PubMed ID: 28161549
[TBL] [Abstract][Full Text] [Related]
32. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
33. Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release.
Chen Z; He N; Chen M; Zhao L; Li X
Acta Biomater; 2016 Oct; 43():195-207. PubMed ID: 27424081
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker.
Zhang X; Tang K; Wang H; Liu Y; Bao B; Fang Y; Zhang X; Lu W
Bioconjug Chem; 2016 May; 27(5):1267-75. PubMed ID: 27070848
[TBL] [Abstract][Full Text] [Related]
35. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J
Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
37. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
38. Carrier-free, functionalized drug nanoparticles for targeted drug delivery.
Li W; Yang Y; Wang C; Liu Z; Zhang X; An F; Diao X; Hao X; Zhang X
Chem Commun (Camb); 2012 Aug; 48(65):8120-2. PubMed ID: 22766919
[TBL] [Abstract][Full Text] [Related]
39. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
40. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
